Generative AI imagines new protein structures
MIT researchers develop “FrameDiff,” a computational tool that uses generative AI to craft new protein structures, with the aim of accelerating drug development and improving gene therapy.
MIT researchers develop “FrameDiff,” a computational tool that uses generative AI to craft new protein structures, with the aim of accelerating drug development and improving gene therapy.
By applying a language model to protein-drug interactions, researchers can quickly screen large libraries of potential drug compounds.
These tunable proteins could be used to create new materials with specific mechanical properties, like toughness or flexibility.
With further development, the programmable system could be used in a range of applications including gene and cancer therapies.